Search Results 521-530 of 4624 for 谷歌搜索留痕工具咨询邮箱：lgooxc@hotmail.com

  1. Contact Information

    Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...

  2. A Study of Leukemia Inhibitory Factor Biomarker Monitoring Progression and Treatment Response of Locally-advanced Unresectable and Metastatic Pancreatic Cancer Therapies - Mayo Clinic

    The purpose of this study is to determine if LIF (Leukemia Inhibitory Factor) level is positively correlated with disease progression and CA19-9 level in ...

  3. A Study of High Resolution Impedance Manometry versus Direct Mucosal Impedance Catheter for Diagnostic Measurements in Patients with Gastroesophageal Reflux Disorder - Mayo Clinic

    The purpose of this study is to evaluate and compare esophageal high resolution impedance manometry (HRIM) with direct mucosal impedance catheter diagnostic ...

  4. ARrest RESpiraTory Failure From PNEUMONIA - Mayo Clinic

    The purpose of this study is to establish the effectiveness of a combination of an inhaled corticosteroid and a beta agonist compared to placebo for the ...

  5. Development of an Evidenced-Based Tool for Prediction of Sudden Death in Patients With Non-Ischemic Cardiomyopathy - Mayo Clinic

    About this study. This study is an observational study to determine predictors of sudden cardiac death or appropriate ICD therapy in patients with ...

  6. Spine Surgery Recall Bias - Clinical Trials

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. AI-Driven, FDG-PET Based Approach to Track Disease Progression and Evolution to Phenoconversion in Progranulin Mutation Carriers - Mayo Clinic

    The purpose of this study is to develop an AI-driven biomarker based on FDG-PET images to track longitudinal brain changes in asymptomatic (n = 15) and ...

  8. Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma - Mayo Clinic

    This is a Phase Ib, open-label, multicenter, global study designed to assess the safety and tolerability of RO6870810 as monotherapy and in combination with ...

  9. Publications - Zeying Du, M.D., Ph.D. - Mayo Clinic

    Du Z, Murrin ME, Kendrick JR, Williams CD, Elrefaei M. A Nine-Nucleotide Insertion Causes the Novel HLA-C*06:402 Allele in a Family Detected by ...

  10. A Study of Poziotinib in Patients with NSCLC With EGFR or HER2 Exon 20 Insertion Mutation - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and the safety/tolerability of poziotinib in patients with NSCLC exon 20 insertion mutations.